Neohelmanthicin A (compound 3A) is a phenylpropanoid compound with antitumor activity. The IC 50 s of Neohelmanthicin A for inhibiting leukemia cell line EL4, breast cancer cell line S180 and breast cancer cell line MCF7 are 0.13 μM, 7 μM and 23 μM respectively.
Products | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.